Question.1140 - Step 1 and Step 2 of Project 5. I am requesting this portion by Saturday, December 1st. This will ensure if any edits are needed I can have time to communicate with the tutor. Milestone deadlines MUST be met in advance. If missed, the opportunity for the professor's feedback ahead of the FINAL Project is completely lost. -------Submit a six- to seven-page marketing strategy. The marketing strategy should include all components outlined in Step 1 and Step 2 of Project 5.----- Must use resources found within the class and other scholarly texts. Project 5 asks you to identify a medical device for MediCorp that the company can use as a vehicle for expanding into another country. *My medical device is a nebulizer and the country is Indonesia.* Please communicate soon if you have any questions. Again, I provide the template as soon as I see it posted in the classroom.
Answer Below:
MediCorp xxxxxxxxx Strategy xxx Nebulizer xx Indonesia xxxxxxxxx Before xxxxxx hit xxxxxxxxx the xxxxxx was xxxxxxx to xxxxxx acute xxxxxxxxxxx infection xxxx as xxxxxxx in xxxxx cast xxxx burden xx the xxxxxxxxxx system xxxxxxx to xxxxxxx various xxxxxxxxxxx ailments xxxx asthma xxxx and xxxxx respiratory xxxxxxxxx causing xxxxxxxxx breath xxxxxxxxxx and xxxxxxx fevers xx defined xx WHO xxxx et xxx recent xxxxxxxxx in xxxxxxxxxx with xxx population xxxx state xxxx around xxxxxxx people xxx exposed xxx are xxxxxxx to xxxxxxxxxxx illness xxxxxxxxxxxx asthma xxxx et xxxx the xxxxxx in xxxxxxxxxx and xxxxxxx public xxxxxxxxxx aid xx the xxxxxx SARI xxx become xx acute xxxxxxxxxxx illness xxxxxxx patients xxxx shown xxxxx of xxxxxxx fevers xx C xxxx severe xxxxx this xxx the xxxxxx in x strong xxxxxx for xxxxxxxxx respiratory xxxxxxxxx like xx nebulizer xxxx could xxxx result xx preventive xxxxxxxx to xxxxxx pulmonary xxxxxxxx at xxx grassroots xxxxx Aman xx Endaryanto xx al xxxxxx worsened xxx situation xxxxxx Indonesia xxxxxxx hypoxia xxxxxxx to xxxxx damage xxxx people xxxx prolonged xxxxxxxx and xxxxxxxxxxxx healthcare xx Indonesia xxx been xxxxxxxxx due xx inappropriate xxxxxxxxxx infrastructure xxxx is xxxxxx accessible xxx children xxxx also xxxxxx for x home-based xxxxxxxxx approach xxxxxxxxxxx respiratory xxxxxx in xxxxxxxx that xxx the xxxx generation xx risk xx inherent xxxxxxxxxxxx nosocomial xxxxxxxxxxxx and xxxx Kahar xx al xxxxxxxxx offers x convenient xxx effective xxx to xxxxxxx respiratory xxxxxxxx at xxxx which xxx also xx monitored xxxxxxxxxxxx by xxxxxxx guardians xxxxxxxxxx Main xxxxxxxxxxx in xxxxxxxxxxx Medical xxxxxxxxxxx Devices xxxxxxxx In xxxxx of xxxxxxxxxxx the xxxxxxxxxxx it xx important xxx MediCorp xx conduct x comprehensive xxxxxxxx in xxxxx of xxxxxx assessment xxx nebulizers xx conducting x SWOT xxxxxxxx MediCorp xxxx be xxxx to xxxxxxxx strengths xxxxxxxxxx market xxxxx in xxxxx of xxxxxxxxxx the xxxxxxxxxxx and xxxx for xxxxxxxxx within xxx domestic xxx international xxxxxx International xxxxxxxx Differences x d xxxxxxxx MediCorp xxxxxx monitor xxxxxxxxxx trends xx assess xxx market xxxxxxxxxxx One xx the xxxxxx observed xx Indonesia xxxxxxxxxxxxx where xxxx of xxxxxxxx influence xxxx patients xx terms xx hospitalization xxx expenditure xxxxx cost xxxx in xxxxx of xxxxxxxx diagnosis xxx research xx W xxxxxxx claims xxxx certain xxxx kits xxxx spirometry xxxxxxxx bronchoscopy xxx thoracoscopy xxxx utilized xx diagnose xxxxxxxxx with xxxxxxxxx cost xxxxxx under xxx name xx COVID- xxxxxxxxx pushing xxx people xx avoid xxxxxxxx care xxxxxxxx a xxxxxx for xxxxxxxxxx and xxxx care xxx illness xxxxxxxxx the xxxxxxxx to xxxxxx the xxxx market xxxxxxxxxxx and xxxxxxxxxx of xxx future xxxxxxxx needs xx tap xxxx the xxxxxxx demand xxx portable xxxxxxxxxx through xxxxxxx health xxxxxxxxxxx N xxxxxxxx Researching xxxxxx growth xxxxxxxxxxx in xxxxxxxxx needs xx involve xxxxxxx factors xxxx population xxxxxx expenditure xxxxxx and xxxxxxxxxx of xxxxxxxxxxx conditions xxxxxxxx needs xx stay xxxxxxx on xxxxxxxxxx healthcare xxx industrial xxxxxxxx that xxxxxx the xxxxxxx sector xx that xxx company xxx draft x dynamic xxx adaptable xxxxxxxxxxx market xxxxxxxxxxxx MediCorp xxxxx to xxxxxxxx the xxxxxxxxxxxx including xxx gender xxxxxxxx and xxxxxxxxxx infrastructure xxxxx rural xx order xx mitigate xxx prevalence xx respiratory xxxxxxxxxx to xxxxxxxxx nebulizers xxxx the xxxxxx through x strategy xxxx is xxxxxxxx for xxx target xxxxxxxxxx Endaryanto xx al xx is xxxxxxxxx for xxxxxxxx to xxxxxxxx a xxxxxxxxxx forecast xx order xx develop x grassroots xxxx that xxxxxxx challenges xxxx supply xxxxx disruptions xxxxxxxxxxxx due xx economic xxxxxxxx and xxxxxxxxxx changes xxx be xxxxxxx Recommendation xxx Relocation xxxxx Porters xxxxx Chain xxxxxxxx Inbound xxxxxxxxx by xxxxxxxxxx the xxxxxxxxxxx of xxxxxxxx raw xxxxxxxxx and xxxxxxxxxx locally xx reduce xxxxx improve xxxxxx chain xxxxxxxxxx and xxxxxxx local xxxxxxxxxxxxx initiatives xxxxx operations xxx be xxxxxxxxx by xxxxxxxxxxx setting xx local xxxxxxxxxxxxx or xxxxxxxx units xx Indonesia xx enhance xxxxxxxxxx reduce xxxxxxxxxxxxxx costs xxx expedite xxxxxxx delivery xxxxxxxx Value xxxxx n x Outbound xxxxxxxxx by xxxxxxxxxx distribution xxxxxxxx by xxxxxxxxxxxx partnerships xxxx local xxxxxxxxx providers xx ensure xxxxxx and xxxxxxxxxxxxxx product xxxxxxxx across xxx country xxxxxxxx Value xxxxx n x Marketing xxx Sales xx developing xxxxxxxxx marketing xxxxxxxxxx tailored xx Indonesian xxxxxxxx nuances xxxxxxxx preferences xxx media xxxxxxxxxxx habits xxxxxxxxxxxxx Cultural xxxxxxxxxxx n x Service xxxxxx by xxxxxxxxxxxx local xxxxxxx centers xx provide xxxxxx and xxxxxxxxx maintenance xxxxxxxxxxxxxxx and xxxxxxxx support xxxxx Addition xx MediCorp xxx Competitive xxxx Competitive xxxxxxxxx In xxxxx of xxxxxxx and xxxxxxxxxx Leverage xxxxxxxxxx expertise xx genetic xxxxxxx devices xx ensure xxx highest xxxxxxx and xxxxxxxxxx in xxxxxxxxx production xxxxxxxxx et xx Secondly xx terms xx user-friendly xxxxxxx Develop xxxxxxxxxxxxx nebulizers xxxx intuitive xxxxxxxxxx clear xxxxxxxxxxxx and xxxx maintenance xxxxxxxx Lastly xxxxxxxx needs xx develop xxx adapt xx technological xxxxxxxxxxxx Incorporate xxxxxxxxxxxxx advancements xxxx smart xxxxxxxxxx with xxxxxxxxx connectivity xxxxxx app xxxxxxxxxxx and xxxxxxxxxxxx treatment xxxxx and xxxx ensure xxxxxxxxxxxxx with xxxxxxx health xxxxxxx and xxxxxxxx devices xx facilitate xxxx sharing xxx remote xxxxxxx monitoring xxxxx Business xxxxxx and xxxxx of xxxxx Analyze xxxxx structures xxx marketing xxxxxxx devices xx Indonesia xxxx as xxxxxxxxxxxx a xxxxx subsidiary xxxxxxx a xxxxx venture xxxx an xxxxxxxxxx company xx partnering xxxx a xxxxx distributor xxxxx of xxxxx n x Consider xxxxx of xxxxx such xx partnerships xxxx local xxxxxxxxxx to xxxxxxx resources xx wholly-owned xxxxxxxxxxxx based xx regulatory xxxxxxxxxxxx and xxxx assessment xxxxx of xxxxx n x Impact xx Legal xxxxxxx and xxxxxxxx Standards xxxxxxxxx Governance xxx Accountability xxxxxxxx adhere xx Indonesian xxxxxxxxxxx legal xxxxxxxxx regarding xxxxxxx device xxxxxxxxxxxxx testing xxxxxxxx marketing xxx sales xxxxx business xxxxxxxxx with xxxxxxxxxxxxx ethical xxxxxxxxx such xx patient xxxxxxx data xxxxxxxxxx and xxxxxxxxxxx advertising xxxxx marketing xxx communication xxxxxxxxxx to xxxxxxx Indonesian xxxxxxxx norms xxxxxx and xxxxxxxxxxx regarding xxxxxxxxxx matters xx the xxxx develop xxxxxxxxxxxxxx frameworks xxxx are xxxxxxx in xxxxxxxxxx with xx implementation xx transparent xxx accountable xxxxxxxxx for xxxxxxxxxxxxxxx financial xxxxxxxxxx and xxxxxxxxxxx engagement xxxxxxxxxx and xxxxxxxxxxxxxx n x Lastly xxxxx the xxxxxxxxx points xxxx local xxxxxxxxxx expectations xxx international xxxx practices xxxxxxxxxx Strategies xxxx can xx employed xx MediCorpLaunch xx extensive xxxxxxxxxxx campaign xx raise xxxxxxxxx about xxxxxxxxxxx health xxx the xxxxxxxx of xxxxxxxxx usage xxxxx with xxxxxxxxxxxxx with xxxxxxxxxx professionals xxxxxxx and xxxxxxxxx centers xx organize xxxxxxxxx seminars xxx training xxxxxxxx on xxxxxxxxxxx respiratory xxxxxxxx preventive xxxxxxxx and xxx proper xxx of xxxxxxxxxx give xxxx emphasis xx domestic xxxxxxxxxxxx to xxxxxxx them xxxxxxxxx Utilize xxxxxxx media xxxxxxxx including xxxxxx media xx disseminate xxxxxxxxxxx content xxxx partnerships xxxx local xxxxxxxxxx organizations xxxx and xxxxxxxxx health xxxxxxx to xxxxxxx free xxxxxxxxxxx health xxxxxxxxx and xxxxxxxxx demonstrations xxxxx Offer xxxxxxxxxx or xxxxxxxxxx nebulizers xxx those xx need xxxxxxxxxx in xxxxxxxxxxx areas xxxxx not xxxx addresses xxx immediate xxxxxxxxxx needs xx the xxxxxxxxx but xxxx establishes x positive xxxxx image xxx MediCorp xxxxxxxx the xxxxx of xxxxxxxxx acceptance xx telehealth xxxxxxxx in xxxxxxxxx and xxxxxxx a xxxxxxxxxx platform xxxx allows xxxxx to xxxxxxx with xxxxxxxxxx professionals xxxxxxxx for xxxxxxxxxxx issues xxxxxxxxx Sridhar xxxxxxxxx nebulizer xxxxx guidance xxxxxxxxxx and xxxxxxxxxxxx services xxxx the xxxxxxxx to xxxxxxx a xxxxxxxx respiratory xxxx solution xx order xx align xxxx the xxxxxxx preference xxx home-based xxxxxxxxxx Implement xxxxxxxxx Social xxxxxxxxxxxxxx CSR xxxxxxxxxxx focused xx respiratory xxxxxx wherein xxxxxxxx can xxxxxxx local xxxxxx sports xxxxxxxxxx or xxxxxxxx programs xxxx a xxxxx emphasis xx promoting xxxxxxxxxxx wellness xxxxxxxxx et xx Allocate x portion xx nebulizer xxxxx towards xxxxxxx respiratory xxxxxx initiatives xxx awareness xxxxxxxx demonstrating x commitment xx the xxxxxxxxxxx well-being xxxxxxxxxxxxxxx MediCorp's xxxxxxxxxx through xxxxxxxxxx packaging xxx user-friendly xxxxxxx by xxxxxxxxxxx eco-friendly xxxxxxxxx options xx appeal xx environmentally xxxxxxxxx consumers xxxxxxxxxxxxx The xxxx is xx make xxx product xxx only xxxxxxxxx but xxxx visually xxxxxxxxx and xxxx to xxx Establish x dedicated xxxx for xxxxxxxxxx market xxxxxxxxxx to xxxx ahead xx emerging xxxxxx consumer xxxxxxxxxxx and xxxxxxxxxx strategies xxxxxxxxx Regularly xxxxxx the xxxxxxxxx plan xxxxx on xxxxxxxx market xxxxxxxx and xxxxxxxx behaviors xxxx proactive xxxxxxxx ensures xxxx MediCorp xxxxxxx adaptable xxx responsive xx the xxxxxxxx healthcare xxxxxxxxx in xxxxxxxxx Implement xxxxxxxx loyalty xxxxxxxx to xxxxxxxxx repeat xxxxxxxxx and xxxxx loyalty x by xxxxxxxx discounts xx nebulizer xxxxxxxxxxx provide xxxxxxxx warranties xx introduce x points xxxxxx for xxxxx purchase xxxxx Engage xxxx customers xxxxxxx newsletters xxx exclusive xxxxxxx on xxxxxxxxxxx health xxxxxxxxx a xxxxxxxxx relationship xxxxxx the xxxxxxx sale xxxxxxxxxx ties xxxx healthcare xxxxxxxxxxxxx by xxxxxxxx training xxxxxxxx workshops xxx continuous xxxxxxxxx on xxx latest xxxxxxxxxxxx in xxxxxxxxxxx care xxxxxxxxxxxxx Establish x network xx healthcare xxxxxxxxx endorsing xxx prescribing xxxxxxxxxx nebulizers xxxxxxxxx credibility xxx trust xxxxx potential xxxxxxxxx Actively xxxxxxxxx and xxxxxxxx user xxxxxxx and xxxxxxxxxxxx on xxxxxxx platforms xxxxxx a xxxxxxx on xxx company xxxxxxx dedicated xx success xxxxxxx and xxxxxxxx experiences xxxx MediCorp's xxxxxxxxxx This xxxxxx trust xxxxx potential xxxxxxxxx and xxxxxx as xxxxxxxxx proof xx the xxxxxxxxx effectiveness xxxxxxxxxx This xxxxxxxxx strategy xxxxxxxxxx MediCorp's xxxxxxxxx in xxxxxxx testing xxxxxxx with xxx growing xxxxxx for xxxxxxxxxxx care xx Indonesia xx strategically xxxxxxxxxx market xxxxxxxx competition xxx value xxxxxxxx MediCorp xxx position xxxxxx as x key xxxxxx in xxxxxxxxxxx medical xxxxxxxxxxx devices xxxxxxxx The xxxxxxxx relocation xxx entry xxxxxxxxxx aim xx optimize xxxxxxxxxx while xxxxxxxxxx local xxxxx ethical xxx cultural xxxxxxxxx References xxxx A x Wibawa x Kosasih x Asdie x H xxxxxxx I xxxxxxxxx U x Lau x Y xxxxxxxxxx of xxxxxx acute xxxxxxxxxxx infection xxxx and xxxxxxxxxxxx of xxxxxxxxx in xxxxxxxxx Influenza xxx Other xxxxxxxxxxx Viruses x Endaryanto x Dewi x Nugraha x A xxxxx in xxx admissions xx patients xxxx non-COVID- xxxxxxxxxxx symptoms xxxxxx COVID- xxxxxxxx and xxx impact xx hospital xxxxxxxx in xxxxxxxx Indonesia xxxxxxx Gbadamosi x Contemporary xxxxxx in xxxxxxxxx Principles xxx practice xxxxxxxxxxxx Issues xx Marketing x Kahar x Dirawan x D xxxxx S xxxxxxxxx N xxxxxxxx D x The xxxxxxxxxxxx of xxxxxx attitudes xxx behaviors xx the xxxxxxxxx during xxx Covid xxxxxxxx in xxxxxxxxx structure xxxxxxxx Topic xxxxxxxxxx and xxxxxxxxxxxxxx Governance xxx Accountability x d xxxxx leocontent xxxx edu xxxxxxx scor xxxxxxxxx mba xxxx learning-topic-list xxxxxxxxxxxxxxxxxxxxxxxxxxxxx html xx Learning xxxxx International xxxxxxxx Differences xxxxxxxxxxxxx Cultural xxxxxxxxxxx n x https xxxxxxxxxx umgc xxx content xxxx uncurated xxx -mba xxxxxxxxxxxxxxxxxxx international-cultural-differences xxxx ou xxxxxxxx Topic xxxxx of xxxxx Modes xx Entry x d xxxxx leocontent xxxx edu xxxxxxx scor xxxxxxxxx mba xxxx learning-topic-list xxxxxxxxxxxxxx html xx Learning xxxxx Porter's xxxxx Chain xxxxxxxx Value xxxxx n x https xxxxxxxxxx umgc xxx content xxxx uncurated xxx -mba xxxxxxxxxxxxxxxxxxx value-chain xxxx ou xxxxx N xxx manager's xxxxx to xxxxxxxxxxx marketing xxxxxxxxxx Routledge xxxxxxxxx R x Sridhar x Marketing xxxxxxxx Based xx first xxxxxxxxxx and xxxx analytics xxxxxxxxxx Publishing xxxxxxxxx Jr x D xxxxxx J x McCarthy x J xxxxxxxxxx of xxxxxxxxx A xxxxxxxxx strategy xxxxxxxx approach xxxxxxxxxxx Purnomo x P xxxxxxxxx F x Trisnawati x W xxxxxxx R xxxxx Observed xxxx of xxxxxx fire xxxxxxxx effects xx respiratory xxxxxxxx by xxxxxxx in xxxx Province xxxxxxxxx In xxx Conference xxxxxx Earth xxx Environmental xxxxxxx Vol xx p xxx Publishing xxxxxxxxxxxxx B x Global xxxxxxxxx strategy xxxxxxxx International xxxxxxxxxxMore Articles From Management
.ico)
.ico)
.ico)
.ico)
